H. Manganas

1.6k total citations
38 papers, 736 citations indexed

About

H. Manganas is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, H. Manganas has authored 38 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 15 papers in Physiology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in H. Manganas's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (34 papers), Sarcoidosis and Beryllium Toxicity Research (14 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers). H. Manganas is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (34 papers), Sarcoidosis and Beryllium Toxicity Research (14 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers). H. Manganas collaborates with scholars based in Canada, United States and Australia. H. Manganas's co-authors include Christopher J. Ryerson, Kerri A. Johannson, Charlene D. Fell, Martin Kolb, Nasreen Khalil, Julie Morisset, Jolene H. Fisher, Shane Shapera, Deborah Assayag and Harold R. Collard and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and European Respiratory Journal.

In The Last Decade

H. Manganas

33 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Manganas Canada 13 585 218 100 78 55 38 736
Levent Cem Mutlu Türkiye 12 501 0.9× 277 1.3× 36 0.4× 44 0.6× 72 1.3× 34 736
Sinem Güngör Türkiye 13 363 0.6× 205 0.9× 28 0.3× 17 0.2× 54 1.0× 51 532
P Fazzi Italy 11 327 0.6× 235 1.1× 21 0.2× 26 0.3× 53 1.0× 23 469
J.‐L. Guilmot France 10 174 0.3× 162 0.7× 45 0.5× 207 2.7× 104 1.9× 28 551
Lidwien Graat‐Verboom Netherlands 7 385 0.7× 129 0.6× 22 0.2× 38 0.5× 31 0.6× 10 543
Piotr Boros Poland 13 660 1.1× 399 1.8× 57 0.6× 7 0.1× 55 1.0× 41 771
Zewu Zhu China 16 346 0.6× 32 0.1× 27 0.3× 18 0.2× 64 1.2× 56 605
Jung Keun Choi South Korea 7 215 0.4× 97 0.4× 31 0.3× 11 0.1× 33 0.6× 14 419
Edward M. Cordasco United States 14 409 0.7× 94 0.4× 31 0.3× 14 0.2× 63 1.1× 40 614
James Tolle United States 7 446 0.8× 37 0.2× 57 0.6× 50 0.6× 75 1.4× 18 551

Countries citing papers authored by H. Manganas

Since Specialization
Citations

This map shows the geographic impact of H. Manganas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Manganas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Manganas more than expected).

Fields of papers citing papers by H. Manganas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Manganas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Manganas. The network helps show where H. Manganas may publish in the future.

Co-authorship network of co-authors of H. Manganas

This figure shows the co-authorship network connecting the top 25 collaborators of H. Manganas. A scholar is included among the top collaborators of H. Manganas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Manganas. H. Manganas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Assayag, Deborah, Xiaoping Chen, Jolene H. Fisher, et al.. (2025). Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 211(10). 1846–1854. 1 indexed citations
2.
Donaldson, M, Deborah Assayag, Jolene H. Fisher, et al.. (2024). Characteristics of pulse oximetry and arterial blood gas in patients with fibrotic interstitial lung disease. BMJ Open Respiratory Research. 11(1). e002250–e002250.
3.
Mahone, Michèle, et al.. (2024). Anti-synthetase syndrome diagnosed during pregnancy: a case report and literature review. Scandinavian Journal of Rheumatology. 53(3). 229–232.
4.
Khor, Yet H., Kerri A. Johannson, Veronica Marcoux, et al.. (2024). Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 210(8). 1035–1044. 10 indexed citations
5.
Fortin, Marc, Moïshe Liberman, Antoine Delage, et al.. (2023). Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy: A Prospective Multi-Centre Agreement Clinical Trial (CAN-ICE). American Journal of Respiratory and Critical Care Medicine. 207(12). 1612–1619. 16 indexed citations
6.
Zheng, Boyang, Alyson W. Wong, Deborah Assayag, et al.. (2023). Impact of Antigen Exposure on Outcomes and Treatment Response in Fibrotic Hypersensitivity Pneumonitis. CHEST Journal. 165(6). 1435–1443. 3 indexed citations
7.
Marcoux, Veronica, Prosanta Mondal, Deborah Assayag, et al.. (2023). Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort. Journal of Thoracic Disease. 15(5). 2517–2527. 6 indexed citations
8.
Zheng, Boyang, Nathan Hambly, Kerri A. Johannson, et al.. (2022). Clinical relevance of rheumatoid factor and anti‐citrullinated peptides in fibrotic interstitial lung disease. Respirology. 27(10). 854–862. 2 indexed citations
9.
Khor, Yet H., Nicole Goh, Alyson W. Wong, et al.. (2022). Impact of Concomitant Medication Burden on Tolerability of Disease-targeted Therapy and Survival in Interstitial Lung Disease. Annals of the American Thoracic Society. 19(6). 962–970. 9 indexed citations
10.
Khor, Yet H., Mohammed A. Farooqi, Nathan Hambly, et al.. (2022). Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease. CHEST Journal. 163(2). 345–357. 7 indexed citations
11.
Assayag, Deborah, Kerri A. Johannson, Charlene D. Fell, et al.. (2021). Treatment Initiation in Patients with Interstitial Lung Disease in Canada. Annals of the American Thoracic Society. 18(10). 1661–1668. 7 indexed citations
12.
Shapera, Shane, Christopher J. Ryerson, Deborah Assayag, et al.. (2021). Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study. Respiratory Medicine. 191. 106722–106722. 6 indexed citations
13.
Fisher, Jolene H., Kerri A. Johannson, Deborah Assayag, et al.. (2020). Long-term monitoring of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society Position Statement. Canadian Journal of Respiratory Critical Care and Sleep Medicine. 4(3). 147–155. 10 indexed citations
14.
Sadatsafavi, Mohsen, Jolene H. Fisher, Julie Morisset, et al.. (2020). Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease–associated Interstitial Lung Disease. Annals of the American Thoracic Society. 17(9). 1077–1084. 5 indexed citations
15.
Wong, Alyson W., Deborah Assayag, Kerri A. Johannson, et al.. (2020). Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease. Thorax. 76(1). 37–43. 38 indexed citations
16.
Fisher, Jolene H., Martin Kolb, Kerri A. Johannson, et al.. (2019). Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis. BMC Pulmonary Medicine. 19(1). 223–223. 53 indexed citations
17.
Sadatsafavi, Mohsen, Jolene H. Fisher, Julie Morisset, et al.. (2019). Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease. CHEST Journal. 156(5). 887–895. 15 indexed citations
18.
Boucher, Vincent Gosselin, Julie Morisset, H. Manganas, et al.. (2019). Effects of Pursed Lip Breathing on Exercise Capacity and Dyspnea in Patients With Interstitial Lung Disease. Journal of Cardiopulmonary Rehabilitation and Prevention. 39(2). 112–117. 12 indexed citations
19.
Levy, Robert D., John Yee, N. Partovi, et al.. (2018). Successful lung transplantation in an HIV seropositive patient with desquamative interstitial pneumonia: a case report. BMC Pulmonary Medicine. 18(1). 162–162. 9 indexed citations
20.
Ryerson, Christopher J., Charlene D. Fell, H. Manganas, et al.. (2016). The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry. Canadian Respiratory Journal. 2016. 1–7. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Levent Cem Mutlu Breakdown of academic impact, for papers by Sinem Güngör Breakdown of academic impact, for papers by P Fazzi Breakdown of academic impact, for papers by J.‐L. Guilmot Breakdown of academic impact, for papers by Lidwien Graat‐Verboom Breakdown of academic impact, for papers by Piotr Boros Breakdown of academic impact, for papers by Zewu Zhu Breakdown of academic impact, for papers by Jung Keun Choi Breakdown of academic impact, for papers by Edward M. Cordasco Breakdown of academic impact, for papers by James Tolle
Rankless by CCL
2026